The evidence leans constructive8 supporting, 1 against, 0 worth knowing
Supporting
trading 30% above its 200-day average
sitting at 100% of its 52-week range, with little overhead supply from trapped buyers
up 39% over twelve months
matches made a new 52-week high today, which has beaten the market by +1.12 points over 20 sessions across 9,689 past signals
11 of the scans it matches have a positive measured record
5 independent kinds of evidence agree today, which is uncommon
revenue grew 49% year on year in the quarter ending 30 June 2026
net margin has widened from 8.8% to 11.6% across four quarters
Against
1 of the scans it matches has historically underperformed the market
Worth knowing
nothing the data supports either way
What would change this read: a close below 4,779, its 200-day average; a failure to hold the top of its 52-week range.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working7
Net profit rose 101.6% year on year, from Rs 40 cr to Rs 80 cr.
+101.6%Rs 40 crRs 80 cr
Revenue rose 49.1% year on year, from Rs 462 cr to Rs 689 cr.
+49.1%Rs 462 crRs 689 cr
Profit grew faster than revenue, +101.6% against +49.1%.
+101.6%+49.1%
Trading 30.3% above its 200-day average, which is the line most investors use to separate a bull phase from a bear one.
+30.3%
Within 0.0% of its 52-week high.
-0.0%
Up 39.1% over the past year.
+39.1%
3 different kinds of evidence point at it tonight, not 3 versions of the same one.
3 families
Needs watching
Nothing on this side tonight — not in the filings and not in the price.
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 3 of these 3 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
15 of 47 matched on 10 Sep
KINGFA matches 15 of the 47 scans today, across 5 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
KINGFA trades at 37× trailing earnings, close to its median of 35× over this window. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202) · Results filings were typically -0.51pt vs the market over the next 5 sessions (n=7,726) · Dividend filings were typically +0.16pt vs the market over the next 5 sessions (n=940)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 49% against the same quarter a year earlier
profit rose 102% year on year
net margin widened from 10.2% to 11.6%
revenue rose in 4 of the last 4 quarters
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · standalone
689
108
80
59.19
11.6%
Q4 FY26
31 Mar · standalone
578
80
59
43.65
10.2%
Q3 FY26
31 Dec · standalone
489
61
45
33.34
9.2%
Q2 FY26
30 Sep · standalone
466
55
41
30.36
8.8%
Q1 FY26
30 Jun · standalone
462
54
40
32.86
8.6%
Q4 FY25
31 Mar · standalone
470
54
42
34.60
8.9%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+12.9%
Versus 200-day average+30.3%
Below 52-week high+0.0%
Above 52-week low+65.7%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)68.1
Higher closes in last 54 of 5
Six-month return+47.25%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)2.81%
Volume versus 20-day2.6x
Median daily turnoverRs 7.4 cr
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.